BRPI0911420A2 - Cepa de lactobacilo paracasei, subespécies paracasei dotada de propriedades antimicribianas e imunomoduladoras - Google Patents

Cepa de lactobacilo paracasei, subespécies paracasei dotada de propriedades antimicribianas e imunomoduladoras

Info

Publication number
BRPI0911420A2
BRPI0911420A2 BRPI0911420-3A BRPI0911420A BRPI0911420A2 BR PI0911420 A2 BRPI0911420 A2 BR PI0911420A2 BR PI0911420 A BRPI0911420 A BR PI0911420A BR PI0911420 A2 BRPI0911420 A2 BR PI0911420A2
Authority
BR
Brazil
Prior art keywords
paracasei
antimicribian
subspecies
immunomodulatory properties
strain
Prior art date
Application number
BRPI0911420-3A
Other languages
English (en)
Inventor
Isabelle Chambaud
Artem Khlebnikov
Anne-Catherine Villain
Gianfranco Grompone
Thierry Saint Denis
Anne Druesne
Tamara Smokvina
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of BRPI0911420A2 publication Critical patent/BRPI0911420A2/pt
Publication of BRPI0911420A8 publication Critical patent/BRPI0911420A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Animal Husbandry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI0911420A 2008-04-18 2009-04-16 cepa de lactobacilo paracasei, subespécies paracasei dotada de propriedades antimicrobianas e imunomoduladoras BRPI0911420A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0802158A FR2930264B1 (fr) 2008-04-18 2008-04-18 Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices.
PCT/FR2009/000443 WO2009130423A2 (fr) 2008-04-18 2009-04-16 Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices

Publications (2)

Publication Number Publication Date
BRPI0911420A2 true BRPI0911420A2 (pt) 2015-08-04
BRPI0911420A8 BRPI0911420A8 (pt) 2016-06-28

Family

ID=39720249

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911420A BRPI0911420A8 (pt) 2008-04-18 2009-04-16 cepa de lactobacilo paracasei, subespécies paracasei dotada de propriedades antimicrobianas e imunomoduladoras

Country Status (16)

Country Link
US (1) US8557561B2 (pt)
EP (1) EP2271744B1 (pt)
JP (1) JP5649564B2 (pt)
KR (1) KR101609401B1 (pt)
CN (1) CN102066550B (pt)
AR (1) AR071330A1 (pt)
BR (1) BRPI0911420A8 (pt)
CA (1) CA2721704C (pt)
CL (1) CL2009000911A1 (pt)
ES (1) ES2410263T3 (pt)
FR (1) FR2930264B1 (pt)
MX (1) MX2010011465A (pt)
PL (1) PL2271744T3 (pt)
RU (1) RU2501850C2 (pt)
WO (1) WO2009130423A2 (pt)
ZA (1) ZA201007510B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8372392B2 (en) * 2009-12-23 2013-02-12 Lytone Enterprise, Inc. Lactobacillus paracasei strain LT12 as immunity regulatory agent
WO2011141762A1 (en) 2010-05-12 2011-11-17 Compagnie Gervais Danone Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
CA2805208C (en) 2010-07-15 2019-11-26 Compagnie Gervais Danone Use of manganese for enhancing the growth of l. casei in mixed cultures
CN103550258B (zh) * 2010-12-08 2015-08-05 益擎生技股份有限公司 乳酸菌株调节免疫反应的用途
WO2012133827A1 (ja) * 2011-03-31 2012-10-04 森永乳業株式会社 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
EA028377B1 (ru) * 2011-04-08 2017-11-30 Кр. Хансен А/С Противомикробная композиция
US9539281B2 (en) 2011-07-12 2017-01-10 The Brigham And Women's Hospital, Inc. Lipid-containing PSA compositions, methods of isolation and methods of use thereof
WO2013019896A1 (en) * 2011-08-01 2013-02-07 Symbiotix Biotherapies, Inc. Platform for identifying and/or characterizing immunomodulatory agents
ES2402014B1 (es) * 2011-09-07 2014-02-27 Consejo Superior De Investigaciones Científicas (Csic) Peptido secretado por lactobacillus plantarum con función inmunomoduladora
CA2855906A1 (en) * 2011-12-01 2013-06-06 Compagnie Gervais Danone Lactobacillus paracasei subsp. paracasei, as an agent for inhibiting listeria monocytogenes in vivo infection
WO2013174792A1 (en) 2012-05-21 2013-11-28 Dupont Nutrition Biosciences Aps Strains of lactobacillus with antifungal properties
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
WO2014204578A1 (en) 2013-06-21 2014-12-24 The General Hospital Corporation Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
CN112301024A (zh) 2013-03-15 2021-02-02 通用医疗公司 使用RNA引导的FokI核酸酶(RFN)提高RNA引导的基因组编辑的特异性
KR101614262B1 (ko) 2013-07-12 2016-04-20 모리나가 뉴교 가부시키가이샤 신규 유산균, 그리고 신규 유산균을 함유하는 의약, 음식품 및 사료
CN114836340A (zh) * 2013-11-29 2022-08-02 晨晖生物科技股份有限公司 乳酸菌株及引物组
CN104862240A (zh) * 2013-12-28 2015-08-26 萧夏青 乳酸菌株及其引物组
WO2015159124A1 (en) * 2014-04-15 2015-10-22 Compagnie Gervais Danone Use of lactobacillus paracasei for promoting intestinal clearance of opportunistic pathogens after antibiotic dysbiosis
CN104523762B (zh) * 2014-12-10 2019-01-22 中国农业大学 具有抗过敏作用的副干酪乳杆菌的应用和功能食品组合物及其制备方法
GB201506509D0 (en) 2015-04-16 2015-06-03 Univ Wageningen Nuclease-mediated genome editing
US10648020B2 (en) 2015-06-18 2020-05-12 The Broad Institute, Inc. CRISPR enzymes and systems
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
JP6918365B2 (ja) 2015-08-19 2021-08-11 プレジデント アンド フェローズ オブ ハーバード カレッジ 脂質化ｐｓａ組成物および方法
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US9926546B2 (en) 2015-08-28 2018-03-27 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US12110490B2 (en) 2015-12-18 2024-10-08 The Broad Institute, Inc. CRISPR enzymes and systems
BR112018014104B1 (pt) 2016-01-21 2022-11-29 Chr. Hansen A/S Método de produzir um produto lácteo fermentado,composição e produto alimentício
EP3445853A1 (en) 2016-04-19 2019-02-27 The Broad Institute, Inc. Cpf1 complexes with reduced indel activity
KR20260004568A (ko) 2016-04-19 2026-01-08 더 브로드 인스티튜트, 인코퍼레이티드 신규한 crispr 효소 및 시스템
BR112018071271B1 (pt) 2016-05-11 2023-04-11 Chr. Hansen A/S Processo para a produção de um produto alimentício de armazenamento ambiente
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
RU2744271C2 (ru) * 2016-12-16 2021-03-04 Компани Жервэ Данон Пробиотическая композиция, содержащая штаммы Lactobacillus rhamnosus и Lactobacillus paracasei
AU2018281511B2 (en) * 2017-06-09 2020-04-16 Sone Farm Co., Ltd. Novel lactic acid bacteria and use thereof
KR102361556B1 (ko) * 2017-06-09 2022-02-09 소네팜 가부시키가이샤 유산균의 균체외 다당 및 그 용도
WO2019147743A1 (en) 2018-01-26 2019-08-01 Massachusetts Institute Of Technology Structure-guided chemical modification of guide rna and its applications
KR102463809B1 (ko) * 2019-05-24 2022-11-04 한국식품연구원 클로스트리디오이데스 디피실레에 항균 활성을 갖는 락토바실러스 파라카세이 WiKim0110 균주 및 이를 포함하는 조성물
WO2020245216A1 (en) * 2019-06-07 2020-12-10 Universite De Lille Novel lactic acid bacteria strain - antibacterial peptides produced by said strain and related pharmaceutical compositions
CN110878270B (zh) * 2019-12-21 2021-08-13 福建省农业科学院农业工程技术研究所 一株副干酪乳杆菌副干酪亚种及其应用
WO2025032353A1 (en) 2023-08-04 2025-02-13 Compagnie Gervais Danone Symbiotic fermented milk products containing a probiotic and storage-stable in situ produced galacto-oligosaccharides
CN117070425B (zh) * 2023-10-10 2024-03-08 广东益可维生物技术有限公司 提高益生菌在机体内代谢稳定性的工艺方法及益生菌冻干粉

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996020607A1 (fr) * 1995-01-02 1996-07-11 Compagnie Gervais Danone Ferment lactique, et son utilisation pour la preparation de produits anti-diarrheiques
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
FR2848115B1 (fr) * 2002-12-05 2005-03-25 Rhodia Chimie Sa Composition de bacteries et son utilisation
US7919277B2 (en) * 2004-04-28 2011-04-05 Danisco A/S Detection and typing of bacterial strains
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics

Also Published As

Publication number Publication date
ZA201007510B (en) 2011-08-31
PL2271744T3 (pl) 2013-08-30
CA2721704A1 (fr) 2009-10-29
AR071330A1 (es) 2010-06-09
EP2271744B1 (fr) 2013-03-20
CA2721704C (fr) 2019-04-02
JP5649564B2 (ja) 2015-01-07
BRPI0911420A8 (pt) 2016-06-28
FR2930264A1 (fr) 2009-10-23
KR20110009152A (ko) 2011-01-27
JP2011517570A (ja) 2011-06-16
CN102066550A (zh) 2011-05-18
ES2410263T3 (es) 2013-07-01
CN102066550B (zh) 2013-10-30
US20110150852A1 (en) 2011-06-23
EP2271744A2 (fr) 2011-01-12
KR101609401B1 (ko) 2016-04-05
RU2010146956A (ru) 2012-05-27
WO2009130423A2 (fr) 2009-10-29
RU2501850C2 (ru) 2013-12-20
US8557561B2 (en) 2013-10-15
WO2009130423A3 (fr) 2009-12-17
MX2010011465A (es) 2011-01-21
CL2009000911A1 (es) 2010-02-19
FR2930264B1 (fr) 2013-02-22

Similar Documents

Publication Publication Date Title
BRPI0911420A2 (pt) Cepa de lactobacilo paracasei, subespécies paracasei dotada de propriedades antimicribianas e imunomoduladoras
DK3248610T5 (da) Fgf21-mutanter og anvendelser deraf
ZA201104224B (en) Oncolytic adenoviral vectors and methods and uses related thereto
ZA201103356B (en) Fgf21 mutants and uses thereof
IL242192A0 (en) Certain chemical substances, preparations and methods
EP2225360A4 (en) DETECTION DEVICES AND METHOD
BRPI0913752A2 (pt) método, dispositivo, e, estrutura
EP3483610C0 (en) FUNCTIONALIZED CHROMOPHOROUS POLYMER DOTS AND THEIR BIOCONJUGATES
BRPI0913227A2 (pt) método, e objeto
IL207096A0 (en) Modified leptin polypeptides and their uses
IL212199A0 (en) Hpma- docetaxel or gemcitabine conjugates and uses therefore
LT1996696T (lt) Termostabilūs loctobacillus kamienai
GB201014198D0 (en) Force element arrangement and method
ZA201103456B (en) Leukolectins and uses thereof
PL2324177T3 (pl) Urządzenie do przemieszczania i zestaw
PL2247601T3 (pl) Tiazopirymidynony i ich zastosowanie
BRPI0906654A2 (pt) Válvula de gaveta, e, gaveta
PT2326193E (pt) Luva com propriedades isolantes ajustáveis
EP2242858A4 (en) ISOTHERMAL DETECTION METHODS AND USES THEREOF
SI2376479T1 (sl) Substituirani furankarboksamidi in njihova uporaba
BRPI0820958A2 (pt) Intermediário, e, composto
BRPI1008599A2 (pt) derivação magnética, disposição de derivação magnética e dispositivo de força
AP2409A (en) Novel enterococcus and streptococcus strains and bacteriocins.
GB0707069D0 (en) Methods and uses
BRPI0909760A2 (pt) Cepa de lactobacillus rhamnosus

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]